Vulcan Value Partners Portfolio holdings
Vulcan Value Partners is a value investing firm founded in 2007 by C.T. Fitzpatrick, a former principal and portfolio manager at Southeastern Asset Management. Fitzpatrick is its principal owner, chief investment officer and chief executive. Its analysts look for publicly traded companies that are competitively entrenched and can be bought at a margin of safety, keeping a shortlist of stable businesses they call the MVP list. Vulcan runs these strategies through individually managed portfolios, mutual funds and private funds for individuals and institutions, including charities and pension plans. Enduring Equity Holdings, formerly a Vulcan subsidiary, became an independent company at the end of 2025.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$432M |
| 2 |
Cardinal Health
CAH
|
+$313M |
| 3 |
Cencora
COR
|
+$304M |
| 4 |
McKesson
MCK
|
+$261M |
| 5 |
CBRE Group
CBRE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Templeton
BEN
|
+$329M |
| 2 |
Parker-Hannifin
PH
|
+$252M |
| 3 |
T. Rowe Price
TROW
|
+$161M |
| 4 |
Boeing
BA
|
+$149M |
| 5 |
RTX
RTX
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.88% |
| 2 | Healthcare | 19.41% |
| 3 | Technology | 18.48% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Industrials | 7.62% |
Similar funds
Vulcan Value Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Vulcan Value Partners held 67 positions worth $11.2B, up 3.1% from $10.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Vulcan Value Partners's Q4 2016 filing shows 9 new, 16 increased, 29 reduced and 13 closed positions. Its largest new stake was CVS Health: 5,334,307 shares worth $421M. The largest sale was Franklin Templeton, an estimated $329M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 33% a quarter earlier, followed by Healthcare and Technology.
- Vulcan Value Partners's largest Q4 2016 buy was CVS Health: 5,334,307 shares worth $421M.
- Vulcan Value Partners added most to Cencora in Q4 2016, an estimated $304M increase.
- Vulcan Value Partners's biggest Q4 2016 reduction was Franklin Templeton, cutting an estimated $329M.
- Vulcan Value Partners fully exited T. Rowe Price in Q4 2016, selling an estimated $161M.
- Vulcan Value Partners's ten largest holdings make up 44% of its $11.2B portfolio in Q4 2016.
- Vulcan Value Partners opened 9 new positions and closed 13 in Q4 2016.
- Vulcan Value Partners's portfolio value rose 3.1% quarter-over-quarter to $11.2B.
Based on Vulcan Value Partners's 13F filing for Q4 2016, filed 14 Feb 2017.